Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Line Borgwardt

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Journal of Clinical Immunology|June 8, 2026
Novel Partial Loss-of-function STAT3-variant as Cause of Hyper-IgE-Syndrome in a Danish Family with Variable ExpressivityCamilla Heldbjerg Drabe, Jonathan Gehrig, Jens Magnus Bernth Jensen, et al.
AIDS Research and Therapy|May 2, 2024
The association between single-nucleotide polymorphisms within type 1 interferon pathway genes and human immunodeficiency virus type 1 viral load in antiretroviral-naïve participantsSara Bohnstedt Mørup, Preston Leung, Cavan Reilly, et al.
Journal of Inherited Metabolic Disease|May 31, 2018
Efficacy and safety of Velmanase alfa in the treatment of patients with alpha-mannosidosis: results from the core and extension phase analysis of a phase III multicentre, double-blind, randomised, placebo-controlled trialLine Borgwardt, Nathalie Guffon, Yasmina Amraoui, et al.
Immunity, Inflammation and Disease|March 12, 2026
Investigating the Impact of Host Genetics on the Risk of Disease Progression in Individuals With InfluenzaSara Bohnstedt Mørup, Maja Milojevic, Seyed Mahmood Taghavi Shahri, et al.
Journal of Inherited Metabolic Disease|May 5, 2018
Comprehensive long-term efficacy and safety of recombinant human alpha-mannosidase (velmanase alfa) treatment in patients with alpha-mannosidosisAllan M Lund, Line Borgwardt, Federica Cattaneo, et al.
The Journal of Experimental Medicine|April 20, 2022
Life-threatening viral disease in a novel form of autosomal recessive IFNAR2 deficiency in the ArcticChristopher J A Duncan, Morten K Skouboe, Sophie Howarth, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Journal of Clinical Immunology|June 8, 2026
Novel Partial Loss-of-function STAT3-variant as Cause of Hyper-IgE-Syndrome in a Danish Family with Variable ExpressivityCamilla Heldbjerg Drabe, Jonathan Gehrig, Jens Magnus Bernth Jensen, et al.
AIDS Research and Therapy|May 2, 2024
The association between single-nucleotide polymorphisms within type 1 interferon pathway genes and human immunodeficiency virus type 1 viral load in antiretroviral-naïve participantsSara Bohnstedt Mørup, Preston Leung, Cavan Reilly, et al.
Journal of Inherited Metabolic Disease|May 31, 2018
Efficacy and safety of Velmanase alfa in the treatment of patients with alpha-mannosidosis: results from the core and extension phase analysis of a phase III multicentre, double-blind, randomised, placebo-controlled trialLine Borgwardt, Nathalie Guffon, Yasmina Amraoui, et al.
Immunity, Inflammation and Disease|March 12, 2026
Investigating the Impact of Host Genetics on the Risk of Disease Progression in Individuals With InfluenzaSara Bohnstedt Mørup, Maja Milojevic, Seyed Mahmood Taghavi Shahri, et al.
Journal of Inherited Metabolic Disease|May 5, 2018
Comprehensive long-term efficacy and safety of recombinant human alpha-mannosidase (velmanase alfa) treatment in patients with alpha-mannosidosisAllan M Lund, Line Borgwardt, Federica Cattaneo, et al.
The Journal of Experimental Medicine|April 20, 2022
Life-threatening viral disease in a novel form of autosomal recessive IFNAR2 deficiency in the ArcticChristopher J A Duncan, Morten K Skouboe, Sophie Howarth, et al.
Pageof 3